Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Expression of phospholipase C isozymes in human breast cancer and their clinical significance.

Cai S, Sun PH, Resaul J, Shi L, Jiang A, Satherley LK, Davies EL, Ruge F, Douglas-Jones A, Jiang WG, Ye L.

Oncol Rep. 2017 Mar;37(3):1707-1715. doi: 10.3892/or.2017.5394. Epub 2017 Jan 20.

PMID:
28112359
2.

Tumour suppressor function of MDA-7/IL-24 in human breast cancer.

Patani N, Douglas-Jones A, Mansel R, Jiang W, Mokbel K.

Cancer Cell Int. 2010 Aug 24;10:29. doi: 10.1186/1475-2867-10-29.

3.

Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour.

Morgan JM, Douglas-Jones AG, Gupta SK.

Histopathology. 2010 Mar;56(4):489-500. doi: 10.1111/j.1365-2559.2010.03514.x.

PMID:
20459556
4.

Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.

Cheng S, Douglas-Jones A, Yang X, Mansel RE, Jiang WG.

Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):67-73.

PMID:
20335520
5.

Metastasis of Primary Colon Cancer to the Breast - Leave Well Alone.

Barthelmes L, Simpson JS, Douglas-Jones AG, Sweetland HM.

Breast Care (Basel). 2010 Mar;5(1):23-25. Epub 2010 Feb 23.

6.

Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer.

Baruah BP, Goyal A, Young P, Douglas-Jones AG, Mansel RE.

Br J Surg. 2010 May;97(5):680-3. doi: 10.1002/bjs.6964.

PMID:
20186888
7.

Measurement of lymph node function from the extraction of immunoglobulin in lymph.

Fowler JC, Britton TB, Provenzano E, Ravichandran D, Lawrence D, Solanki CK, Ballinger JR, Douglas-Jones A, Mortimer PS, Purushotham AD, Peters AM.

Scand J Clin Lab Invest. 2010 Apr;70(2):112-5. doi: 10.3109/00365510903572040.

PMID:
20141499
8.

PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance.

Escudero-Esparza A, Martin TA, Douglas-Jones A, Mansel RE, Jiang WG.

Oncol Rep. 2010 Feb;23(2):537-44.

PMID:
20043119
9.

Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer.

Fernando H, Martin TA, Douglas-Jones A, Kynaston HG, Mansel RE, Jiang WG.

Exp Ther Med. 2010 Jan;1(1):153-160. Epub 2010 Jan 1.

10.
11.

Screening at breast reduction. More than a little extra work.

Douglas-Jones AG, Varma M.

BMJ. 2009 Jun 9;338:b2342. doi: 10.1136/bmj.b2342. No abstract available.

PMID:
19509047
12.

Molecular assessment of sentinel lymph node in breast cancer management.

Douglas-Jones AG, Woods V.

Histopathology. 2009 Jul;55(1):107-13. doi: 10.1111/j.1365-2559.2008.03218.x. Review.

PMID:
19469912
13.

Axillary lymph node drainage pathways from intradermal and intraparenchymal breast planes.

Fowler JC, Solanki CK, Ballinger JR, Ravichandran D, Douglas-Jones A, Lawrence D, Bobrow L, Purushotham AD, Peters AM.

J Surg Res. 2010 Jun 1;161(1):69-75. doi: 10.1016/j.jss.2009.01.003. Epub 2009 Jan 31.

PMID:
19439325
14.

Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin.

Hay T, Matthews JR, Pietzka L, Lau A, Cranston A, Nygren AO, Douglas-Jones A, Smith GC, Martin NM, O'Connor M, Clarke AR.

Cancer Res. 2009 May 1;69(9):3850-5. doi: 10.1158/0008-5472.CAN-08-2388. Epub 2009 Apr 21.

15.

A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection.

Fowler JC, Solanki CK, Guenther I, Barber R, Miller F, Bobrow L, Ravichandran D, Lawrence D, Ballinger JR, Douglas-Jones A, Purushotham AD, Peters AM.

Eur J Surg Oncol. 2009 Oct;35(10):1041-7. doi: 10.1016/j.ejso.2009.02.018. Epub 2009 Apr 10.

PMID:
19362444
16.

Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance.

Davies SR, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG.

J Exp Ther Oncol. 2008;7(4):327-38.

PMID:
19227012
17.

Retained surgical swab following breast augmentation: a rare cause of a breast mass.

Baruah BP, Young P, Douglas-Jones A, Mansel R.

BMJ Case Rep. 2009;2009. pii: bcr07.2008.0519. doi: 10.1136/bcr.07.2008.0519. Epub 2009 Feb 26.

18.

Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.

Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L, Mansel RE.

Mol Cancer. 2008 Sep 16;7:71. doi: 10.1186/1476-4598-7-71.

19.

Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.

Mansel RE, Goyal A, Douglas-Jones A, Woods V, Goyal S, Monypenny I, Sweetland H, Newcombe RG, Jasani B.

Breast Cancer Res Treat. 2009 Jun;115(3):595-600. doi: 10.1007/s10549-008-0155-6. Epub 2008 Aug 21.

PMID:
18716862
20.

Expression of the WASP verprolin-homologues (WAVE members) in human breast cancer.

Fernando HS, Davies SR, Chhabra A, Watkins G, Douglas-Jones A, Kynaston H, Mansel RE, Jiang WG.

Oncology. 2007;73(5-6):376-83. doi: 10.1159/000136157. Epub 2008 May 29.

PMID:
18509249
21.

Angiopoietins lack of prognostic significance in ductal mammary carcinoma.

Rmali KA, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG.

Int Semin Surg Oncol. 2007 Mar 23;4:6.

22.
23.

Radial scar lesions of the breast diagnosed by needle core biopsy: analysis of cases containing occult malignancy.

Douglas-Jones AG, Denson JL, Cox AC, Harries IB, Stevens G.

J Clin Pathol. 2007 Mar;60(3):295-8. Epub 2006 May 26.

24.

Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens.

Shah VI, Flowers CI, Douglas-Jones AG, Dallimore NS, Rashid M.

Histopathology. 2006 May;48(6):683-91.

PMID:
16681684
25.

Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.

Salem AA, Douglas-Jones AG, Sweetland HM, Mansel RE.

Eur J Surg Oncol. 2006 Jun;32(5):484-7. Epub 2006 Mar 29.

PMID:
16569493
26.

Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer.

Jiang WG, Watkins G, Douglas-Jones A, Mansel RE.

Prostaglandins Leukot Essent Fatty Acids. 2006 Apr;74(4):235-45. Epub 2006 Mar 23.

PMID:
16556493
27.

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.

Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE.

Breast Cancer Res Treat. 2006 Aug;98(3):311-4. Epub 2006 Mar 22.

PMID:
16552627
28.

Measurement of estrogen receptor status by immunocytochemistry in paraffin wax sections.

Jasani B, Douglas-Jones A, Rhodes A, Wozniak S, Barrett-Lee PJ, Gee J, Nicholson R.

Methods Mol Med. 2006;120:127-46.

PMID:
16491599
29.
30.

Lymphocytic lobulitis in breast core biopsy: a peritumoral phenomenon.

Douglas-Jones AG.

Histopathology. 2006 Jan;48(2):209-12. No abstract available.

PMID:
16405676
31.

Leiomyosarcoma of the inferior vena cava: clinical experience with four cases.

Abisi S, Morris-Stiff GJ, Scott-Coombes D, Williams IM, Douglas-Jones AG, Puntis MC.

World J Surg Oncol. 2006 Jan 4;4:1.

32.

Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.

Jiang WG, Douglas-Jones AG, Mansel RE.

Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):125-34. Epub 2005 Dec 20.

PMID:
16364620
33.

Metastatic cutaneous Crohn's disease of the nipple: report of a case.

Goyal A, Mansel RE, Young HL, Douglas-Jones A.

Dis Colon Rectum. 2006 Jan;49(1):132-4.

PMID:
16283564
34.

Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer.

Watkins G, Douglas-Jones A, Mansel RE, Jiang WG.

Int Semin Surg Oncol. 2005 Oct 26;2:23.

35.

The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer.

Kang H, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG.

Breast. 2005 Oct;14(5):360-7.

36.

Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.

Jiang WG, Raz A, Douglas-Jones A, Mansel RE.

J Histochem Cytochem. 2006 Feb;54(2):231-41. Epub 2005 Oct 3.

PMID:
16204225
37.
38.

Mucin-secreting papillary adenocarcinoma of the hyoid bone: a unique case.

Burnell I, Tomkinson A, Hourihan M, Robinson M, Douglas-Jones A.

J Laryngol Otol. 2005 Jun;119(6):498-502. Review.

PMID:
15992484
39.
40.

Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.

Jiang WG, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE, Fodstad O.

Int J Cancer. 2005 Dec 10;117(5):730-7.

41.

Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.

Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE.

Eur J Cancer. 2005 Jul;41(11):1628-36.

PMID:
15951164
42.

Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer.

Goyal A, Douglas-Jones AG, Newcombe RG, Mansel RE.

Breast J. 2005 May-Jun;11(3):188-94.

PMID:
15871704
43.

Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.

Watkins G, Douglas-Jones A, Bryce R, Mansel RE, Jiang WG.

Prostaglandins Leukot Essent Fatty Acids. 2005 Apr;72(4):267-72.

PMID:
15763438
44.

Eosinophilic angiocentric fibrosis and granuloma faciale: analysis of cellular infiltrate and review of literature.

Narayan J, Douglas-Jones AG.

Ann Otol Rhinol Laryngol. 2005 Jan;114(1 Pt 1):35-42. Review.

PMID:
15697160
45.

Mutations in Apc and p53 synergize to promote mammary neoplasia.

Méniel V, Hay T, Douglas-Jones A, Sansom OJ, Clarke AR.

Cancer Res. 2005 Jan 15;65(2):410-6.

46.

Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.

Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE.

Endocr Relat Cancer. 2004 Dec;11(4):781-91.

PMID:
15613452
47.

The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer.

Watkins G, Douglas-Jones A, Mansel RE, Jiang WG.

Oncol Rep. 2004 Aug;12(2):483-8.

PMID:
15254719
48.

Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE; ALMANAC Trialists Group.

Eur J Cancer. 2004 Jul;40(11):1731-7.

PMID:
15251163
49.

Measurement in histopathology.

Douglas-Jones AG.

Histopathology. 2004 Jul;45(1):88-9. No abstract available.

PMID:
15228451
50.

Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes.

Jiang WG, Watkins G, Douglas-Jones A, Mansel RE.

Int J Oncol. 2004 Jul;25(1):81-5.

PMID:
15201992

Supplemental Content

Loading ...
Support Center